Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults.

Chaichana KL, Kosztowski T, Niranjan A, Olivi A, Weingart JD, Laterra J, Brem H, Quiñones-Hinojosa A.

J Neurosurg. 2010 Aug;113(2):286-92. doi: 10.3171/2010.2.JNS091010.

PMID:
20302391
2.

Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.

Chaichana KL, McGirt MJ, Niranjan A, Olivi A, Burger PC, Quinones-Hinojosa A.

Neurol Res. 2009 Nov;31(9):931-9. doi: 10.1179/174313209X395454. Epub 2009 Feb 12.

PMID:
19215664
3.

Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma.

Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, Berger MS.

J Neurosurg. 2006 Jul;105(1):34-40.

PMID:
16871879
4.

Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.

Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A.

J Neurosurg. 2010 Jan;112(1):10-7. doi: 10.3171/2008.10.JNS08608.

PMID:
19361270
5.

Revisiting anaplastic astrocytomas I: an expansive growth pattern is associated with a better prognosis.

Moulding HD, Friedman DP, Curtis M, Kenyon L, Flanders AE, Paek SH, Andrews DW.

J Magn Reson Imaging. 2008 Dec;28(6):1311-21. doi: 10.1002/jmri.21593.

PMID:
19025897
6.

Postoperative imaging surveillance in pediatric pilocytic astrocytomas.

Dorward IG, Luo J, Perry A, Gutmann DH, Mansur DB, Rubin JB, Leonard JR.

J Neurosurg Pediatr. 2010 Oct;6(4):346-52. doi: 10.3171/2010.7.PEDS10129.

PMID:
20887107
7.

Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect.

McGirt MJ, Bulsara KR, Cummings TJ, New KC, Little KM, Friedman HS, Friedman AH.

J Neurosurg. 2003 Jan;98(1):14-20.

PMID:
12546347
8.

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.

Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL.

Neurosurgery. 1997 Nov;41(5):1028-36; discussion 1036-8.

PMID:
9361056
9.

Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.

McGirt MJ, Chaichana KL, Gathinji M, Attenello F, Than K, Ruiz AJ, Olivi A, Quiñones-Hinojosa A.

Neurosurgery. 2008 Aug;63(2):286-91; discussion 291. doi: 10.1227/01.NEU.0000315282.61035.48.

PMID:
18797358
10.

Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.

Garcés-Ambrossi GL, McGirt MJ, Mehta VA, Sciubba DM, Witham TF, Bydon A, Wolinksy JP, Jallo GI, Gokaslan ZL.

J Neurosurg Spine. 2009 Nov;11(5):591-9. doi: 10.3171/2009.4.SPINE08159.

PMID:
19929363
11.

Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.

Babu R, Bagley JH, Park JG, Friedman AH, Adamson C.

J Neurosurg. 2013 Aug;119(2):434-41. doi: 10.3171/2013.4.JNS122329. Epub 2013 May 10.

PMID:
23662821
12.

Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.

Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, Smith KA, Spetzler RF, Preul MC.

J Neurosurg. 2012 Jun;116(6):1172-81. doi: 10.3171/2012.2.JNS102032. Epub 2012 Mar 16.

PMID:
22424566
13.

Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.

Varughese RK, Lind-Landström T, Habberstad AH, Salvesen Ø, Haug CS, Sundstrøm S, Torp SH.

J Clin Pathol. 2016 Jan;69(1):26-34. doi: 10.1136/jclinpath-2015-202983. Epub 2015 Jul 17.

PMID:
26188054
14.

Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas.

Ekici MA, Bulut T, Tucer B, Kurtsoy A.

Turk Neurosurg. 2011;21(3):271-9. doi: 10.5137/1019-5149.JTN.3321-10.3.

15.

Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.

McGirt MJ, Goldstein IM, Chaichana KL, Tobias ME, Kothbauer KF, Jallo GI.

Neurosurgery. 2008 Jul;63(1):55-60; discussion 60-1. doi: 10.1227/01.NEU.0000335070.37943.09.

PMID:
18728568
16.

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD.

Neurosurgery. 1997 Oct;41(4):776-83; discussion 783-5.

PMID:
9316038
17.

Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?

Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z.

AJNR Am J Neuroradiol. 2009 Apr;30(4):681-8. doi: 10.3174/ajnr.A1465. Epub 2009 Jan 29.

18.

Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors.

Gallo P, Cecchi PC, Locatelli F, Rizzo P, Ghimenton C, Gerosa M, Pinna G.

Br J Neurosurg. 2013 Dec;27(6):759-64. doi: 10.3109/02688697.2013.776666. Epub 2013 Mar 20.

PMID:
23514331
19.

Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Perkins SM, Mitra N, Fei W, Shinohara ET.

J Neurooncol. 2012 Oct;110(1):99-104. doi: 10.1007/s11060-012-0939-8. Epub 2012 Jul 28.

PMID:
22843450
20.

The role of MRI in patients with astrocytoma WHO II treated with fractionated stereotactic radiotherapy.

Plathow C, Lichy MP, Bachert P, Zuna I, Kauczor HU.

Eur Radiol. 2004 Apr;14(4):679-85. Epub 2003 Nov 11.

PMID:
14610685

Supplemental Content

Support Center